Get started
Author

Antoinette Bonaccorso

Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial
2022 · Thomas U Marron, Maria Isabel Fiel, et al. · ˜The œLancet. Gastroenterology & hepatology · 239
Mutations in circulating tumor DNA predict primary resistance to systemic therapies in advanced hepatocellular carcinoma
2020 · Johann von Felden, Amanda J. Craig, et al. · Oncogene · 136
High-density single cell mRNA sequencing to characterize circulating tumor cells in hepatocellular carcinoma
2018 · Delia D’Avola, Carlos Villacorta-Martin, et al. · Scientific Reports · 84
PDF
Laparoscopic resection for Crohn’s disease: an experience with 335 cases
2009 · Scott Quy Nguyen, Ezra Teitelbaum, et al. · Surgical Endoscopy · 65
Transanal total mesorectal excision (taTME) for rectal cancer: beyond the learning curve
2019 · Anthony P. D’Andrea, Elisabeth C. McLemore, et al. · Surgical Endoscopy · 32
Edetate Disodium–Based Chelation for Patients With a Previous Myocardial Infarction and Diabetes
2024 · Gervasio A. Lamas, Kevin J. Anstrom, et al. · JAMA · 28
PDF
Multicenter phase II trial of transanal total mesorectal excision for rectal cancer: preliminary results
2023 · Patricia Sylla, Dana Sands, et al. · Surgical Endoscopy · 26
PDF
Functional Outcomes After Transanal Total Mesorectal Excision (taTME) for Rectal Cancer
2024 · Katherine F. Donovan, Katherine C. Lee, et al. · Annals of Surgery · 11
Oncologic outcomes following transanal total mesorectal excision: the United States experience
2024 · Makda Getachew Zewde, Daniel K. Peyser, et al. · Surgical Endoscopy · 9
Discordance in Total Mesorectal Excision Specimen Grading in a Prospective Phase 2 Multicenter Rectal Cancer Trial
2023 · Patricia Sylla, Mariana Berho, et al. · Annals of Surgery · 6
Multivitamins After Myocardial Infarction in Patients With Diabetes
2025 · Francisco Ujueta, Gervasio A. Lamas, et al. · JAMA Internal Medicine · 4
Abstract CT182: Neoadjuvant cemiplimab demonstrates complete pathological responses in hepatocellular carcinoma
2021 · Thomas Urban Marron, Ganesh Gunasekaran, et al. · Cancer Research · 4
Impact of neoadjuvant treatment on functional outcomes after transanal total mesorectal excision (taTME)—a case series
2025 · Katherine F. Donovan, Elisa Paoluzzi Tomada, et al. · Surgical Endoscopy · 2
Mutations in circulating tumor DNA predict primary resistance to systemic therapies in patients with advanced hepatocellular carcinoma
2020 · Johann von Felden, Amanda J. Craig, et al. · Journal of Hepatology · 2
Long-term Results of the North American Phase II Transanal Total Mesorectal Excision Multicenter Trial for Rectal Cancer
2026 · Katherine F. Donovan, Heather Carmichael, et al. · Annals of Surgery · 1
Impact of Obesity on Postoperative Outcomes in Transanal Total Mesorectal Excision for Rectal Cancer
2025 · Makda G. Zewde, Daniel K. Peyser, et al. · Diseases of the Colon & Rectum
Single-cell mRNA sequencing to characterize circulating tumor cells in hepatocellular carcinoma
2018 · D. D’avola, C. Villacorta, et al. · Journal of Hepatology
Works count: 17
Citation count: 649
H-index: 9
I10-index: 8
Year
Topic
Type